【结 构 式】 |
【分子编号】20350 【品名】5,11-dimethyl-6H-pyrido[4,3-b]carbazol-9-ol 【CA登记号】 |
【 分 子 式 】C17H14N2O 【 分 子 量 】262.31104 【元素组成】C 77.84% H 5.38% N 10.68% O 6.1% |
与该中间体有关的原料药合成路线共 2 条
合成路线1
该中间体在本合成路线中的序号:(II)The iodide is formed as follows: 9-Methoxy-ellipticine (I) (extracted from Ochrosia maculata) is demethylated by refluxing with pyridine hydrochloride to give 9-hydroxy-ellipticine (II), which is then treated with methyl iodide in DMF at room temperature.
【1】 Le Pecq, J.B.; et al. (ANVAR (Agence Natl. Valor. Rech.)); Derivatives of 9-hydroxy-ellipticine and a process fo their preparation. CH 616937; DE 2618223; FR 2308365; GB 1508388 . |
【2】 Woodman, R.J.; NSC-264137. Drugs Fut 1979, 4, 4, 267. |
合成路线2
该中间体在本合成路线中的序号:(I)By reaction of 9-hydroxyellipticine (I) with 2-(diethylamino)ethyl chloride (II) in DMF at 100 C.
【1】 Gros, P.; Crisafulli, E. (CNRS (Centre National de la Recherche Scientifique); Sanofi-Synthélabo); Hydrochlorides of 2-aminoalkyl-9-hydroxyellipticinium chloride derivs. and pharmaceutical compsns. containing them. EP 0209511; FR 2584409; JP 1987010084; US 4897398 . |
【2】 Eastland, G. Jr.; Prous, J.; Castaner, J.; DATELLIPTIUM CHLORIDE < Rec INN >. Drugs Fut 1989, 14, 2, 109. |
Extended Information